"Leica" Bond Ready-to-Use Primary Antibody Bcl-2 (bcl-2/100/D5) (Non-Sterile) - Taiwan Registration 67582f554012c368d9e2daf0b161dc91
Access comprehensive regulatory information for "Leica" Bond Ready-to-Use Primary Antibody Bcl-2 (bcl-2/100/D5) (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 67582f554012c368d9e2daf0b161dc91 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
67582f554012c368d9e2daf0b161dc91
Ministry of Health Medical Device Import No. 019845
DHA09401984500
Product Details
Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
B Hematology and pathology devices
B1860 Immunopathological histochemical reagents and kits
Imported from abroad
Dates and Status
Nov 26, 2018
Nov 26, 2028